Urinary excretion of α-GST and albumin in rheumatoid arthritis patients treated with methotrexate or other DMARDs alone or in combination with NSAIDs

Scandinavian Journal of Rheumatology

Volumn 34, Issue 1, 2005, Pages 34-39

  Svendsen, Kristina Bacher ^a,d   Ellingsen, T ^b   Bech, J N ^a,c   Pfeiffer Jensen, M ^b   Stengaard Pedersen, K ^b   Pedersen, E B ^a,c  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c HOLSTEBRO HOSPITAL   (Denmark)

^d NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AURANOFIN; AUROTHIOMALATE; AZATHIOPRINE; C REACTIVE PROTEIN; CREATININE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUTATHIONE TRANSFERASE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DRUG EFFECT; ENZYME IMMUNOASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; KIDNEY FUNCTION; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; PRIORITY JOURNAL; PROTEINURIA; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; TEST STRIP; TURBIDIMETRY; URINARY EXCRETION;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CREATININE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUTATHIONE TRANSFERASE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 15944386387     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740510017977     Document Type: Article

References (27)

1. Boers M, Dijkmans BA, Breedveld FC, Camps JA, Chang PC, van Brummelen P, et al. Subclinical renal dysfunction in rheumatoid arthritis. Arthritis Rheum 1990;33:95-101.
2. Dieppe PA, Doyle DV, Burry HC, Tuckler SM. Renal disease in rheumatoid arthritis. Br Med J 1976;1:611-12.
3. Hall CL. The natural course of gold and penicillamine nephropathy: a long-term study of 54 patients. Adv Exp Med Biol 1989;252:247-56.
4. Ross JH, McGinty F, Brewer DG. Penicillamine nephropathy. Nephron 1980;26:184-6.
5. Stein HB, Schroeder ML, Dillon AM. Penicillamine-induced proteinuria: risk factors. Semin Arthritis Rheum 1986; 15:282-7.
6. Kintzel PE. Anticancer drug-induced kidney disorders. Drug Safety 2001;24:19-38.
7. Seideman P, Muller-Suur R. Renal effects of aspirin and low dose methotrexate in rheumatoid arthritis. Ann Rheum Dis 1993;52:613-15.
8. Kremer JM, Petrillo GF, Hamilton RA. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy. J Rheumatol 1995; 22:38-40.
9. Wen SF. Nephrotoxicities of nonsteroidal anti-inflammatory drugs. J Formos Med Assoc 1997;96:157-71.
10. Sundberg A, Appelkvist EL, Dallner G, Nilsson R. Glutathione transferases in the urine: sensitive methods for detection of kidney damage induced by nephrotoxic agents in humans. Environ Health Perspect 1994;102 Suppl 3:293-6.
11. Sundberg AG, Nilsson R, Appelkvist EL, Dallner G. ELISA procedures for the quantitation of glutathione transferases in the urine. Kidney Int 1995;48:570-5.
12. Feinfeld DA, Bourgoignie JJ, Fleischner G, Goldstein EJ, Biempica L, Arias IM. Ligandinuria in nephrotoxic acute tubular necrosis. Kidney Int 1977;12:387-92.
13. Campbell JA, Corrigall AV, Guy A, Kirsch RE. Immunohistologic localization of alpha, mu, and pi class glutathione S-transferases in human tissues. Cancer 1991; 67:1608-13.
14. Harrison DJ, Kharbanda R, Cunningham DS, McLellan LI, Hayes JD. Distribution of glutathione S-transferase isoenzymes in human kidney: basis for possible markers of renal injury. J Clin Pathol 1989;42:624-8.
15. Feinfeld DA, Fleischner GM, Arias IM. Urinary ligandin and glutathione-S-transferase in gentamicin-induced nephrotoxicity in the rat. Clin Sci (London) 1981;61:123-5.
16. Feinfeld DA, Fuh VL, Safirstein R. Urinary glutathione-S-transferase in cisplatin nephrotoxicity in the rat. J Clin Chem Clin Biochem 1986;24:529-32.
17. Branten AJ, Mulder TP, Peters WH, Assmann KJ, Wetzels JF. Urinary excretion of glutathione S transferases alpha and pi in patients with proteinuria: reflection of the site of tubular injury. Nephron 2000;85:120-6.
18. Gosling P. Microalbuminuria: a marker of systemic disease. Br J Hosp Med 1995;54:285-90.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
20. Hull JH, Hak LJ, Koch GG, Wargin WA, Chi SL, Mattocks AM. Influence of range of renal function and liver disease on predictability of creatinine clearance. Clin Pharmacol Ther 1981;29:516-21,
21. Kerr DNS. The assessment of renal function. Medical education (international) Ltd. Oxford, 1982, pp 1049-1053.
22. James MA, Fotherby MD, Potter JF. Screening tests for microalbuminuria in non-diabetic elderly subjects and their relation to blood pressure. Clin Sci (London) 1995;88:185-90.
23. Pedersen LM, Nordin H, Svensson B, Bliddal H. Microalbuminuria in patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:189-92,
24. Eger EI, Koblin DD, Bowland T, Inoescu P, Laster MJ, Fang X, et al. Nephrotoxicity of servoflurane versus deflurane anesthesia in volunteers. Anesth Analg 1997;84:160-8.
25. Westhuyzen J, Endre ZH, Reece G, Reith DM, Saltissi D, Morgan TJ. Measurement of tubular enzymuria facilities early detection of acute renal failure in the intensive care unit. Nephrol Dial Transplant 2003;18:543-51.
26. Cressey G, Roberts DR, Snowden CP. Renal tubular injury after infrarenal aortic aneurysm repair. J Cardiothorac Vasc Anesth 2002;16:290-3.
27. el Badawi MG, Abdalla MA, Bahakim HM, Fadel RA. Nephrotoxicity of low-dose methotrexate in guinea pigs; an ultrastructural study. Nephron 1996;73:462-6.